Q2 2024

Filed Aug 6, 2024 · 10-Q · 37 days after period end · 0000950170-24-091808

Q2 2024 · 10-Q

Revenue

$998.00K

−97.7% vs Q2 2023

Net Income

-$15.54M

N/M vs Q2 2023

EPS Diluted

-$3.89

N/M vs Q2 2023

Operating Income-$46,408,000N/M

Operating Cash Flow

Same quarter

Metric	Q2 2024	Q2 2023	Q2 2022	Q2 2021
Revenue	$998.00K	$44.32M	$29.81M	$24.36M
Net Income	-$15.54M	-$87.68M	-$72.62M	-$133.99M
EPS Diluted	-$3.89	-$0.90	-$0.78	-$1.45

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Kyntra Bio, Inc. · CIK 921299 · Engraved from SEC EDGAR